Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Spinal cord & DRG stimulation · Tennessee | Spinal cord & DRG stimulation · Texas | |
|---|---|---|
| Surgeons, 2024 | 22 | 99 |
| Medicare fee-for-service cases | 830 | 3,368 |
| Growth since 2019 (Medicare FFS) | +1.8%/yr | +0.4%/yr |
| Forecast cases (Medicare FFS) | 1,040 in 2030 | 4,030 in 2030 |
| Forecast growth | +3.9%/yr to 2030 | +3.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.1 | 1.4 |
| Medicare Advantage share | 57% | 59% |
| Out of hospital | 70% (+21 pts since 2019) | 71% (+26 pts since 2019) |
| Cases per surgeon | 38 | 34 |
| Top 10 surgeons' share | 64% | 29% |
| Surgeons growing | 2 | 7 |
| New since the base year | 2 | 10 |
| Likely to stop billing it | 8 by 2026 | 37 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $13K | $20K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.